The largest database of trusted experimental protocols

Api id 32c

Manufactured by bioMérieux
Sourced in France

The API ID 32C is a biochemical identification system for yeast and yeast-like organisms. It consists of 32 microtubes containing dehydrated biochemical substrates. The organism is inoculated into the API strip, and the resulting patterns of color changes are used to identify the species.

Automatically generated - may contain errors

9 protocols using api id 32c

1

Protein Extraction and MALDI-TOF Identification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Biochemical identification with API ID 32 C (bioMérieux, Marcy-l’Étoile, France) could not be made because the isolate did not reproduce in this system. The ML72254 strain was therefore incubated for 120 h on an SBA plate, followed by protein extraction with formic acid and acetonitrile, and matrix-assisted laser desorption ionization–time of flight (MALDI-TOF; Bruker Microflex LT system; Bruker Daltonics, US) was used for species identification. A threshold score of ≥2 was set as the criterion for accurate species-level identification.
+ Open protocol
+ Expand
2

Characterization of Probiotic Strains

Check if the same lab product or an alternative is used in the 5 most similar protocols
The compounds studied were provided by Gnosis by Lesaffre, a Business Unit of the Lesaffre Group (Marcq-en-Baroeul, France). S. cerevisiae live yeast (referenced GI) is a proprietary, well-characterized strain of Lesaffre registered in the French National Collection of Cultures of Microorganisms (CNCM) under the number I-3856. The S. cerevisiae species was determined by using phenotypic (API®ID32C, Biomerieux Marcy-l’Étoile, France) and genotypic referenced methods (genetic amplification and sequencing of 26S DNA) [51 (link),52 (link)]. Moreover, the strain CNCM I-3856 has been characterized by polymerase chain reaction (PCR) Interdelta typing techniques [53 ] and other genetic methods (e.g., complete genome sequencing). Furthermore, the strain of L. rhamnosus GG (referenced as G 250) is registered in the American Type Culture Collection (ATCC) under the number 53103, and it can be taken as a dietary supplement [54 (link)]. Since April 2020, Lactobacillus rhamnosus has been officially reclassified to Lacticaseibacillus rhamnosus (L. rhamnosus) [55 (link)].
+ Open protocol
+ Expand
3

Yeast Identification via API ID 32C

Check if the same lab product or an alternative is used in the 5 most similar protocols
For identification, each yeast isolate was subjected to the API ID 32C biochemical gallery test (Biomerieux, Ref. 32200) following the manufacturer's instructions. Briefly, five colonies were collected from a pure SDA plate culture (Bioxon®) with a bacteriological loop and suspended in SISS until tube 2 of the McFarland nephelometer reached turbidity (corresponding to about 6 × 108 cells/mL according to the manufacturer's instructions). From the cell suspension, a 100 μL subsample was placed in each gallery well and incubated at 35°C for 48 h. After incubation, the gallery was read with a mini‐API reader to identify the genus and species of the different yeasts.
+ Open protocol
+ Expand
4

Fungal Infection Identification and Antifungal Susceptibility

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood specimens and non-centrifuged peritoneal fluids obtained during surgery (one specimen/patient) were directly inoculated into two bottles of BACTEC media (PLUS aerobic/F and PLUS anaerobic/F; BD Diagnostics, Sparks, MD, USA), which were incubated for a maximum of 7 days, and analyzed using the automated continuous blood culture monitoring BACTEC FX system (BD Diagnostics). The broth was then sub-cultured on Sabouraud Dextrose Agar with Chloramphenicol (SC) when yeast growth was observed. For colonization purposes, pharyngeal and anal exudates were inoculated in Brain Heart Infusion Broth incubated at 37 °C for 24 or 48 h, and then sub-cultured on SC. Urine specimens were directly streaked onto SC. Cultured yeasts were identified based on the macro-microscopic features of the culture, germ tube test, and biochemical tests (VITEK® 2 system bioMérieux, Inc. Hazelwood, MO, USA or API®/ID 32C bioMérieux, Marcy l’Etoile, France).
Antifungal susceptibility tests were performed using Sensititre Yeast One® (TREK Diagnostic Systems Ltd.). The minimum inhibitory concentration (MIC) results for all antifungals, except for amphotericin B, were interpreted by taking into account the species-specific clinical breakpoint suggested by the CLSI [9 ]. In accordance with the literature data, a breakpoint ≤1 μg/ml was selected for amphotericin B to define the isolates as sensitive (S).
+ Open protocol
+ Expand
5

Biochemical Profiling of Lachancea fermentati

Check if the same lab product or an alternative is used in the 5 most similar protocols
Substrate utilization test API ID 32C (BioMérieux, Marcy-l’Étoile, France) was used to analyze the biochemical spectrum of all Lachancea fermentati strains. Preparation of inoculum and inoculation of the strips was performed according to the manufacturers’ instructions. Colonies for the inoculum were grown on YPD agar plates for 48 h at 27°C. After inoculation, API ID 32C strips were incubated for 2 days at 28°C. The samples were evaluated visually by turbidity of the wells, differentiating positive (+), negative (-), and weak (w) growth.
+ Open protocol
+ Expand
6

Comprehensive Microbial Identification Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bacterial identification was performed using conventional methods and with the VITEK-2 Compact system (bioMérieux, Marcy l’Etoile, France). Fungi isolated from Myco F or aerobic bottles were identified by morphological examination on cornmeal agar with Tween 80 and API ID 32C (bioMérieux, Marcy l’Etoile, France). Incompatible results were confirmed via MALDI-TOF MS (bioMérieux, Marcy l’Etoile, France).
+ Open protocol
+ Expand
7

Yeast and Fungal Identification Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
A 100 mL aliquot of melted ice was filtered and the membrane placed on Sabouraud dextrose agar containing chloramphenicol (0.5 g/L) (Liofilchem, Roseto degli Abruzzi, Italy). After 8 days of incubation at 28 °C, yeast colonies were identified using a semi-automated sugar assimilation system (API ID 32C, Biomerieux, Marcy l’Etoile, France), while filamentous fungi were identified by evaluating their macroscopic and microscopic morphological characteristics according to the methods described elsewhere [18 ].
+ Open protocol
+ Expand
8

Characterization and Evaluation of S. cerevisiae Probiotic Strain

Check if the same lab product or an alternative is used in the 5 most similar protocols
The study evaluated the probiotic yeast S. cerevisiae CNCM I-3856. This strain is a proprietary, well-characterized strain of Lesaffre registered in the French National Collection of Cultures of Microorganisms. The S. cerevisiae species was characterized using phenotypic (API® ID32C, Biomerieux SAS) and genotypic referenced methods (genetic amplification and sequencing of 26S DNA)[24 (link),25 (link)]. Moreover, strain I-3856 can be identified via a polymerase chain reaction interdelta typing technique[26 ] and complete genome sequencing. The dose tested was of 8 × 109 CFU provided daily in two capsules of 500 mg each. The probiotic dietary supplement was provided by Gnosis by Lesaffre (a business unit of Lesaffre Group, France) and comprised S. cerevisiae CNCM I-3856 entirely and exclusively. The comparative product was a placebo comprising inactive ingredients, i.e., maize starch and magnesium stearate. All capsules were made from hydroxypropyl methylcellulose of the same size, weight, colour and taste regardless of the group and prepared according to good manufacturing practices. Every subject consumed two capsules of 500 mg per day in the morning, just before breakfast with a glass of water. Compliance was determined through the assessment of returned packaging and interviews of the subjects at each visit.
+ Open protocol
+ Expand
9

Characterization of Saccharomyces cerevisiae CNCM I-3856

Check if the same lab product or an alternative is used in the 5 most similar protocols
The products studied were provided by Lesaffre Human Care (Marcq-en-Baroeul, France). GI is a proprietary, well-characterised strain of Lesaffre, registered in the French National Collection of Cultures of Microorganisms (CNCM) under the number I-3856. The S. cerevisiae species was determined by using phenotypic (API ® ID32C, Biomerieux SAS, Marcy l'Etoile, France) and genotypic reference methods (genetic amplification and sequencing of 26S DNA) (Kurtzman and Robnett, 1997, 1998) . Moreover, strain CNCM I-3856 has been characterised by PCR Interdelta typing techniques (CEN, 2009) and other genetic methods (e.g. complete genome sequencing).
The specification of the probiotic product is ≥5×10 9 cfu/g and the concentration of the batch used for these trials was 1×10 10 cfu/g. Inactivated yeast obtained by drum-drying of live yeast S. cerevisiae CNCM I-3856 was used as the control strain.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!